our outpatient clinics. The presence of CAD was defined by a documented history of acute coronary syndrome (ACS) (including myocardial infarction or unstable angina), previous percutaneous coronary intervention, coronary artery bypass grafting surgery, or positive myocardial perfusion scan for myocardial ischemia. All subjects had a stable diet pattern and cardiovascular medications for ≥3 months before the day of recruitment. Patients who had atrial fibrillation, significant valvular heart diseases or cardiomyopathy, New York Heart Association Class III/IV heart failure, recent ACS and stroke, attended fewer than three clinic follow-ups or were lost to follow-up were excluded.
study design
This was a single center, prospective observational study, which was approved by The Institutional Review Board of The University of Hong Kong. Written informed consent was obtained from all participants. Patients were prospectively recruited between July 2005 and June 2007 from our medical outpatient clinics. Baseline demographic data, cardiovascular risk factors and cardiovascular medications at the time of recruitment were documented. Cardiovascular risk factors, including tobacco smoking, diabetes mellitus, hypercholesterolemia, hypertension, body mass index, and family history of CVD in first-degree relatives younger than 55 years of age were assessed. Hypertension was defined as either resting systolic or diastolic BP ≥140/90 mmHg at two different times or on anti-hypertensive medications. Diabetes and hypercholesterolemia was defined according to current guidelines. 13, 14 Smoking status was recorded as eversmoker (past or current) or non-smoker. Body mass index was calculated as weight in kilograms divided by the square of height in meters. Glomerular filtration rate was calculated using the Modification of Diet in Renal Disease Study equation. 15 Definitions of congestive heart failure and peripheral vascular disease were derived from the current literature. 16, 17 All patients were prospectively followed-up in our outpatient clinic every 3-4 months. Non-invasive BP was measured using an automated BP machine (DINAMAP, PRO100) during each clinic visit with the patient in a sitting position. All recordings were taken three times following a 5-minute rest. The average of the second and third readings was recorded.
Food-frequency questionnaire and Mediterranean score
The dietary intakes of study subjects were estimated by using a validated food frequency questionnaire designed for Chinese populations as described previously. 18, 19 This questionnaire was validated in the Shanghai Women's Health Study and the nutritional conversion into estimated intake of dietary nutrients was performed by a custom-made computer software from the Shanghai Women's Health Study. 19 The Mediterranean-diet score (MDS) was then calculated for each individual. This score is obtained based on the consumption of eight categories of food, all of which could be derived from the food frequency questionnaire. 20 A score of one would be given if the criteria for each category was fulfilled (the cut-off values of which were determined from prior studies) 20 : (i) high consumption of vegetables (men >303 g/day, women >248 g/day), (ii) high consumption of legumes (men >60 g/day, women >49 g/day), (iii) high consumption of fruits (men >249 g/day, women >216 g/day), (iv) high consumption of cereals (men >291 g/day, women >248 g/day), (v) low consumption of meat and meat products (men <109 g/day, women <91 g/day), (vi) low consumption of milk and dairy products (men <201 g/day, women <194 g/ day), (vii) high monounsaturated: saturated fat ratio (>1.6), and (viii) moderate ethanol consumption (<10 g/day).
These values were then adjusted to daily intakes of 2,500 kcal for men and 2,000 kcal for women. 21 
clinical outcomes
During the follow-up period, patients were reviewed regularly for the development of any MACEs (which included cardiovascular mortality, stroke (ischemic or hemorrhagic), and ACS) as well as all-cause mortality. Cardiovascular mortality was defined as death due to lethal cardiac arrhythmias, ACS, congestive heart failure, stroke, pulmonary embolism, aortic dissection, or unexplained sudden death. Stroke was defined as a new neurological deficit fitting the definition of ischemic stroke, cerebral hemorrhage, or cerebral venous thrombosis. 22 ACS comprised of unstable angina/non-ST elevation myocardial infarction and ST elevation myocardial infarction.
Outcome data were retrieved from the medical records and discharge summaries from a territory-wide information network of all public hospitals in Hong Kong. Survival data were also obtained from the Hong Kong Births and Deaths General Register Office.
statistical analysis
Categorical data were presented as numbers and percentages. Continuous variables were expressed as mean ± standard deviation (SD). Outpatient clinic visit-to-visit BPV was defined using the SD and coefficient of variation (100 × SD/ mean) of the systolic and diastolic BP across clinic visits. 23, 24 As the results for SD and coefficient of variation were qualitatively the same, only the results for SD are presented.
The agreement in BPV was examined by calculating the intraclass correlation (ICC) over the follow-up period. For patients with a shorter follow-up period (i.e., those with less than six clinic follow-ups), the ICC between the first and last BP measurement was analyzed. For those with six or more clinic follow-ups, the ICC between the first three and last three measurements was analyzed. Systolic and diastolic BPV were reproducible for both short and long-term followup (ICC 0.79 and 0.77 for systolic BPV and ICC 0.81 and 0.82 for diastolic BPV respectively, all P < 0.05).
The association between systolic BPV and clinical characteristics was evaluated using linear regression. Characteristics investigated included age, sex, body mass index, MDS, cardiovascular risk factors (smoking status, hypertension, diabetes mellitus, and hypercholesterolemia) and cardiovascular-related comorbidities (history of transient ischemic attack or stroke, congestive heart failure, and peripheral vascular disease). Variables with P < 0.1 in univariate analysis were determined and adjusted for in a multivariate linear regression model. Cox proportional hazard models were used to assess the association between BPV and time to occurrence of individual clinical outcomes. The hazard ratios (HRs) and 95% confidence intervals (CIs) of systolic BPV and MDS in prediction of various clinical events were determined in the model adjusted for mean systolic BP, age, gender, cardiovascular risk factors, cardiovascular medications (anti-thrombotic agents, statins, and antihypertensive agents) which were associated (P < 0.1) with the respective end-points in univariate analyses.
A P-value < 0.05 was considered statistically significant. Statistical analyses were performed using SPSS-20.0.
results clinical characteristics and dietary pattern of the study population
During the study period, a total of 291 patients with stable CAD were recruited. Among them, 11 patients had fewer than 3 clinic follow-ups and 6 patients (2%) were lost to follow-up. As a result, 274 CAD patients were included in the final analysis. Their clinical characteristics are shown in Table I . Their mean age was 68 ± 10 years, 77% were male and 68% had underlying hypertension.
The mean number of outpatient clinic visits for each patient was 18 ± 8 (range 3-49) and mean systolic and diastolic BP was 131 ± 12 mm Hg and 74 ± 8 mm Hg. The average visit-to-visit systolic and diastolic BPV as represented by the SD was 14 ± 5 mm Hg and 9 ± 8 mm Hg, respectively.
The daily intake of the various components used to calculate the MDS are summarized in Table II . The mean MDS of the population was 2.6 ± 1.1. About 18.2% of the study population had a MDS of four or more.
clinical outcome
After a mean follow-up of 77 ± 12 months, 44 patients (16.1% of the study population) developed a MACE. These included 13 subjects (4.7% of the study population) who developed a stroke, 20 (7.3%) subjects with ACS and 19 (6.9%) with cardiovascular mortality respectively. About 31 subjects (11.3%) developed all-cause mortality. The annual incidence of stroke, ACS, cardiovascular, and all-cause mortality was 0.8%, 1.2%, 1.1%, and 1.9%, respectively.
Patients who developed a MACE (stroke, ACS, and cardiovascular mortality) or all-cause mortality upon follow-up had significantly greater systolic BPV (all P < 0.05) compared to those who did not develop a MACE or all-cause mortality. However, there was no difference in diastolic BPV between CAD patients with or without a subsequent MACE and allcause mortality. Patients who developed a MACE had significantly lower MDS compared to those who did not develop a MACE (2.1 ± 1.0 vs. 2.7 ± 1.1, P < 0.01). Subsequent analysis revealed that CAD patients who developed a stroke had a lower MDS compared with those who did not develop a stroke (1.8 ± 0.6 vs. 2.7 ± 1.1, P < 0.01), but there were no significant differences in MDS among patients who did and did not develop ACS (2.4 ± 0.9 vs. 2.6 ± 1.1), cardiovascular mortality (2.2 ± 1.3 vs. 2.7 ± 1.1) and all-cause mortality (2.4 ± 1.2 vs. 2.6 ± 1.1; all P > 0.05).
Patients who developed a stroke were also older (74 ± 6 vs. 67 ± 10 years, P < 0.01), had a higher mean systolic BP (139 ± 14 vs. 131 ± 12 mm Hg, P = 0.02), higher body mass index (27 ± 3 vs. 25 ± 3 kg/m 2 , P = 0.01) and had a greater prevalence of heart failure (39% vs. 10%, P < 0.01). There were however, no significant differences in gender, prevalence of smokers, hyperlipidemia, diabetes, lipid profile, HbA1C, renal function, use of statins, anti-thrombotic agents, and anti-hypertensive medications among patients who did and did not develop a stroke.
Mediterranean-style diet and BPV
Clinical characteristics of CAD patients that were significantly associated with systolic BPV are shown in Table III . After adjustment for confounding factors, a high MDS was significantly associated with low systolic BPV (B −0.74, 95% CI −1.27 to −0.21, P < 0.01). Other independent predictors of systolic BPV include age (B 0.12, 95% CI 0.05 to 0.19), underlying hypertension (B 2.77, 95% CI 1.37 to 4.17), diabetes mellitus (B 1.45, 95% CI 0.21 to 2.70) and mean systolic BP (B 0.09, 95% CI 0.02 to 0.15; all P < 0.05).
Among the various components used to calculate the MDS, it was noted that alcohol had the greatest relationship on BPV. Patients who had moderate alcohol consumption had significantly lower systolic BPV compared to those who had no or excessive alcohol intake (SD of systolic BP 13.1 ± 4.7 mm Hg vs. 14.8 ± 5.8 mm Hg, P < 0.01). Other components of the MDS, when analyzed individually, were not significantly associated with BPV (all P > 0.05).
Mediterranean-style diet, BPV and risk of stroke
Multivariate Cox regression analysis identified a higher MDS to be protective against stroke in patients with CAD (HR 0.48, 95% CI 0.24 to 0.94, P = 0.03) (Table IV ). In contrast, a higher systolic BPV was noted to be hazardous in the development of stroke after CAD (HR 1.13, 95% CI 1.03 to 1.24, P < 0.01). Such a relationship was independent to other confounding factors which were also noted to be associated with stroke, including age, mean systolic BP, body mass index and heart failure (all P < 0.1 in univariate analysis). There were however, no associations between MDS and risk of ACS and cardiovascular mortality in patients with CAD (all P > 0.05).
discussion
The results of our study show that among patients with CAD, those who subsequently develop stroke have a higher systolic BPV as well as a lower MDS. The MDS was an independent predictor for BPV such that for every one point increase in MDS, there was an associated 0.74 mm Hg reduction in systolic BPV as represented by the SD. Finally, among patients with CAD, a one point increase in MDS was associated with a 52% reduction in risk of stroke while every one SD increase in systolic BP was associated with a 13% increased risk of stroke.
A raised visit-to-visit BPV has a number of detrimental effects to the systemic vascular bed. Those with a raised BPV have a greater degree of endothelial dysfunction, carotid atherosclerotic burden as well as arterial stiffness. 12 In addition, a raised visit-to-visit BPV is associated with cardiac diastolic dysfunction as well as renal impairment. 25, 26 The long-term beneficial effects of adhering to the Mediterranean diet have been well proven. Among healthy populations, those adopting a Mediterranean-style diet have been shown to reduce total mortality, 27 subsequent risk of CVD, 1,2 cancer, 28 as well as neurodegenerative diseases. 29 Among those with pre-existing CVDs, investigators from the Lyon Diet Heart Study demonstrated that dietary intervention with a Mediterranean-style diet was able to reduce the risk of recurrent cardiovascular events. 30 Trichopoulou et al. 31 further provided evidence from the European Prospective Investigation into Cancer and Nutrition study, that among patients with CVD, those adopting a Mediterranean-style diet (as delineated at baseline), had significantly reduced mortality on follow-up. The beneficial effects of the Mediterranean-style diet were further confirmed recently by Lopez-Garcia et al. 32 in a large cohort of 18,000 patients with CVD. In this study, with a median follow-up of 7.7 years, the dietary intake of patients with CVD were measured serially, and those who adhered to a Mediterranean-style diet were associated with a lower risk of all-cause mortality. 32 The protective mechanisms on the cardiovascular system of the Mediterranean diet are multiple and include a number of hemodynamic, metabolic, and inflammatory effects. Studies have shown that patients adopting a Mediterraneanstyle diet have a lower BP and arterial stiffness 5, 33 ; a more favorable ratio of total to high-density lipoprotein cholesterol, 34 lower oxidized low-density lipoprotein concentrations, 35 as well as lower glucose concentrations. 36 Furthermore, subjects adopting a Mediterranean-style diet were noted to have a lower concentration of inflammatory markers, as well as a lesser degree of endothelial dysfunction and carotid atherosclerosis. 3, 6 Many of the beneficial Table I . Clinical characteristics of the study population Waist-hip circumference ratio 0.9 ± 0.1
History of TIA or stroke, n (%) 16 (6) Heart failure, n (%) 31 (11) Peripheral vascular disease, n (%)
15 (6) Triglyceride, mmol/L 1.5 ± 0.9 Mediterranean-diet score 2.6 ± 1.1
Abbreviations: BP, blood pressure; GFR, glomerular filtration rate; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; SD, standard deviation; TIA, transient ischemic attack. effects of adopting a Mediterranean-style diet, e.g., the improvement in BP, arterial stiffness, endothelial function and carotid atherosclerotic burden, may thus explain the reduced BPV and thus subsequent stroke risk seen in our patients with a high MDS. Our results revealed that among the various components used to calculate the MDS, alcohol intake had the greatest relationship with BPV. Those with mild-moderate alcohol consumption had significantly lower BPV compared to those who took alcohol excessively or did not incorporate alcohol into their daily diet. Indeed, a mild-moderate alcohol consumption has been associated with a lower risk of CAD, 37 stroke, heart failure, as well as sudden death. 38 In contrast, those with a heavy alcohol consumption have an increased risk of stroke, 39 as well as sudden death. 38 While alcohol in low-to-moderate levels may have beneficial effects against atherosclerosis, high-levels of alcohol have proarrhythmic effects. Those with habitual alcohol intake, in addition, have an overall greater sympathetic activity as well as greater surge in morning BP, and may thus explain the increased risk of stroke and sudden cardiac death. 40 There are a number of limitations in our study. First, the study was of a small sample size comprising of ~300 patients with CAD. Whether the Mediterranean-style diet exerts similar protective effects on BPV and whether the protective effects of such a diet is mediated via BPV needs to be explored in randomized controlled trials of larger sample sizes-both among healthy individuals as well as among patients with CVDs. Potential confounding variables, such as the compliance to antihypertensive and statins were not assessed in the current study. Furthermore, the effects of individual components of the Mediterranean-style diet on BPV, and in particular the relationship of alcohol intake on visitto-visit BPV needs to be further explored. Similarly, the effect of other diets (e.g., Dietary Approaches to Stop Hypertension diet, sodium and potassium intake, intake of polyunsaturated fatty acids, etc.) on BPV should also be studied. Moreover, although we postulated that a reduction in BPV in patients taking a Mediterranean-style diet was mediated via a reduction in endothelial function and arterial stiffness, this was not assessed in the current study. Finally, it should be noted that the dietary patterns of the subjects in our study were only ascertained once. The relationships of any changes in dietary patterns with variations in BP could thus not be ascertained.
conclusion
In conclusion, among patients with CAD, a higher MDS is associated with lower visit-to-visit BPV and with lower stroke risk. 
